NATF strives to bring you the most relevant information in the field of thrombosis research and cardiovascular-related illnesses, which includes topics on thrombosis, stroke prevention, atrial fibrillation, and acute coronary syndrome.

Clot Chronicles: Andexanet

Dr. Sam Goldhaber discusses the newest development in anticoagulant medications, a new reversal agent called andexanet. Hello, this is Dr.…